Landmark stem cell trial: Genetic mismatch no longer a barrier to survival
A multicentre trial has demonstrated that patients receiving stem cell transplants from unrelated donors with multiple genetic mismatches can achieve survival rates comparable to those with better-matched donors when using post-transplant cyclophosphamide prophylaxis.


Jitesh Neupane, University of Cambridge
© Clyde Campbell